. The ability to accurately predict a seizure minutes before onset would enable patients to take precautions against injury and would open the door to novel timely treatment to pre-empt or control the impending seizure.
The field of seizure prediction was established in the 1980s, but after >20 years a comprehensive review published in 2007 (ref. 8 ) concluded that "the current literature allows no definite conclusion as to whether seizures are predictable by prospective algorithms." Nevertheless, in the past decade, several innovations have driven the field forward ( fig. 1 ), including the recognition that potential predictors must be robust and that performance evaluation of seizure prediction algorithms must be standardized; the compiling of extensive databases of long-term EEG recordings; the establishment of international seizure prediction competitions; and a prospective trial of a seizure prediction device that provided convincing evidence that prediction of seizures is possible 9 . In addition, ongoing improvements in our understanding of the mechanisms of seizure generation (ictogenesis) have been important; improved understanding means that the mechanisms of transition to seizure or the physiological factors that make transition to seizure more likely can be taken into account in seizure prediction approaches.
In this Review, we first outline the basis of seizure prediction algorithms before discussing the developments from the past decade that provide impetus for future development of the seizure prediction field and for larger scale clinical trials of seizure prediction devices. On the assumption that seizure prediction will progress from a research challenge to clinical reality implemented with devices and integrated algorithms that could be coupled to time-specific treatments, we argue that an approach that is compatible with standards and regulations for medical devices and medical treatments is needed. We also propose an extension of the previous guidelines 8 for the interpretation of seizure prediction studies in the light of new developments, critically assess the findings of recent studies and suggest future work. We argue that improved understanding of the mechanisms of transition from normal brain activity Seizure prediction -ready for a new era Levin Kuhlmann 1, 2, 3 , Klaus Lehnertz 4, 5 *, Mark P. Richardson 6 , Björn Schelter 7 and Hitten P. Zaveri 8 Abstract | Epilepsy is a common disorder characterized by recurrent seizures. An overwhelming majority of people with epilepsy regard the unpredictability of seizures as a major issue. More than 30 years of international effort have been devoted to the prediction of seizures, aiming to remove the burden of unpredictability and to couple novel, time-specific treatment to seizure prediction technology. A highly influential review published in 2007 concluded that insufficient evidence indicated that seizures could be predicted. Since then, several advances have been made, including successful prospective seizure prediction using intracranial EEG in a small number of people in a trial of a real-time seizure prediction device. In this Review , we examine advances in the field, including EEG databases, seizure prediction competitions, the prospective trial mentioned and advances in our understanding of the mechanisms of seizures. We argue that these advances, together with statistical evaluations, set the stage for a resurgence in efforts towards the development of seizure prediction methodologies. We propose new avenues of investigation involving a synergy between mechanisms, models, data, devices and algorithms and refine the existing guidelines for the development of seizure prediction technology to instigate development of a solution that removes the burden of the unpredictability of seizures.
to seizure has the potential to improve seizure prediction and that such improvements will better define and enable leveraging of the synergy between mechanisms, models, data, devices and algorithms.
Seizure prediction algorithms
Seizure prediction algorithms typically follow the same basic scheme ( fig. 2 ). Continuously acquired physiological signals, most commonly intracranial EEG, are analysed with advanced time series analysis methods to identify predictive characteristics (Box 1). These temporally resolved characteristics are in turn used in decision algorithms to trigger an alarm that warns the patient or their carer or to trigger the delivery of pharmacological or non-pharmacological control of seizures in a closed-loop system.
Ideally, a seizure prediction algorithm would forecast seizure onset with sufficient warning for preparation or intervention, with sufficient precision to minimize interruption to an individual's life and with minimal false alarms and unpredicted seizures. Predictions made during the (assumed) pre-ictal period are considered true predictions, and those made outside the pre-ictal period are considered false predictions ( fig. 2c ). Although the approach outlined is widely used, algorithms need further improvement by drawing on knowledge of seizure mechanisms, multimodal imaging and neurophysiology, computational modelling and control theory 10 . Several approaches and guidelines are used to evaluate seizure prediction algorithms 8 . These approaches involve receiver operating characteristic (ROC) curves that assess the true positive rate against the false positive rate during pre-ictal or inter-ictal periods. Approaches that help to determine the clinical utility of an algorithm involve prospective or pseudo-prospective evaluation of sensitivity and measurement of time spent under a false warning 11, 12 . Overall algorithm performance can be quantified and ranked by the area under the curve (AUC) for either true positive rate versus false positive rate or for sensitivity versus portion of time in false warning ( fig. 3) . Ranking of the AUC becomes meaningful only if complemented by statistical evaluation based on random or surrogate predictors.
Developments and innovations
Need for robust predictors. Optimism for seizure prediction was high in the late 20th and early 21st centuries after many algorithms seemed to enable seizure prediction. However, the landmark review in 2007 (ref. 8 ) pointed out that fundamentally flawed methods had been used to demonstrate above-chance performance of seizure prediction algorithms. Subsequent rigorous tests of seizure prediction showed no evidence of abovechance prediction 8 . This key fault of historic literature continues to pervade the field.
No predictive characteristic or pre-ictal biomarker (Box 1) that is universal among people with epilepsy and that can forecast the exact time of an individual's next seizure has been identified 9, [13] [14] [15] [16] [17] [18] . Typically, a time window in which a seizure is likely to occur is determined. With a longer time window, the prediction is more likely to be correct, even if the so-called predictor has no predictive value. This observation poses the question of how we can determine whether potential seizure predictors do actually predict seizures rather than merely identify random fluctuations in physiological signals that have no association with seizures. This key challenge in seizure prediction -which is often neglected -requires standardized rigorous statistical evaluation of predictive performance 8 because seizure events are relatively rare, and seizure-free intervals are often long.
A simple approach to such analysis is to compare the performance of a prediction algorithm with that of a random predictor 11, 19 that generates predictions at random times at the same rate as that of the algorithm. If required, a random predictor can be adjusted to account for a person's diurnal variation in seizure distribution or other characteristics 15 . More-advanced approaches make use of Monte Carlo simulations (and other such simulations) to generate predictor surrogates, such as the random shifting of seizure times to generate false seizure times [20] [21] [22] . The performance of the prediction algorithm is then statistically compared with the performance of these predictor surrogates. Comparison with a random predictor is computationally the most efficient form of statistical evaluation of performance of a prediction algorithm. Surrogate-based approaches are more time-intensive but offer greater confidence in determining whether or not an algorithm performs better than chance and can account for the nonrandom occurrence of seizures. Awareness of the importance of statistical evaluation of seizure prediction algorithms is critical for understanding the value of the results of seizure prediction studies.
Databases and associated studies. The development of seizure prediction algorithms is critically dependent on the availability of continuous, annotated, longterm data. Such data sets enable researchers to generate hypotheses and statistically validate prospective algorithms. Historically, few investigators have had access to comprehensive data 23 . Recognition of this limitation prompted substantial international efforts during the
Key points
• one clinical trial has shown that prospective seizure prediction in humans is possible.
• Databases of eeG data provide a standard reference for comparison of seizure prediction algorithms and for hypothesis generation.
• competitions provide a platform for identification of the best seizure prediction algorithms.
• the network theory of epilepsy, multimodal recording techniques, long-term monitoring and computational modelling are providing new approaches to seizure prediction.
• the field is ready for a large-scale clinical trial of seizure prediction.
past decade to provide universal access to multichannel, multi-day EEG data that include sleep, wakefulness and activities of daily life to provide a pseudo-realistic test bed.
Two major publicly available databases have resulted from this unprecedented effort. One is the EPILEPSIAE database (see Related links) 24, 25 , which superseded the smaller FSPEEG database 12 that comprised noncontinuous data sets. The other is the IEEG.org database (see Related links) 26, 27 , which also provides the infrastructure to remotely process data within the database. In addition, individual research groups have created databases, including the new Epilepsy Ecosystem 13 database (see Related links), which offers access to long-term data sets 9 from a period of up to 3 years in a few people with epilepsy.
Data from these databases have formed the basis of many seizure prediction studies and have an ongoing effect on retrospective evaluation of seizure prediction algorithms. Several seizure prediction algorithms have been developed on the basis of these databases since the comprehensive review of seizure prediction in 2007 (ref. 8 ) (Supplementary Tables 1&2) , though their adherence to the guidelines in that review varies (Supplementary Box 1). When considering these studies, it is important to note that the results are sensitive to the kind of data used: some studies include data from seizure periods (ictal), seizure-free intervals (inter-ictal), pre-seizure periods (pre-ictal) and post-seizure periods (post-ictal), whereas others focus on non-continuous selected pre-ictal and inter-ictal data. The specificity of the latter studies cannot be accurately assessed owing to selection bias in the inter-ictal data.
Many algorithms have been applied to data from the seizure prediction databases. Studies in which algorithms were applied to subsets of data, to recordings that were short, or to non-continuous data have generally indicated better algorithm sensitivity, lower false positive rates and less time in false warning periods than studies in which long-term recordings were used. This observation can probably be attributed to in-sample testing and selection bias in studies in which non-continuous data have been used, a limited number of seizures among the data and a limited amount of data from inter-ictal periods. Algorithms that have been assessed with small data sets will, therefore, have to be re-evaluated with larger data sets to assess their true contribution to seizure prediction.
The principal finding from studies of these databases is that individual-specific, above-chance seizure prediction seems to be achievable. Before the creation of larger databases, research involved very limited amounts of data, and many conflicting claims were made regarding seizure prediction performance 8 . Prediction times in relation to the seizure onset and the duration of an assumed pre-ictal period vary widely across studies and individuals, suggesting that seizure prediction algorithms should be specific to an individual and/or to the intervention that would be used upon prediction. The findings also suggest that neurophysiological understanding of the pre-ictal state must be improved to determine whether universal mechanisms lead to the variety of observed pre-ictal states. Despite being well annotated, databases were not designed to provide deep insights into seizure-generating mechanisms. Nevertheless, databases can provide indirect insights into potential mechanisms. For example, seizure prediction on the basis of long-term data can be sensitive to the different phases of the sleep-wake cycle 15, 28 . Whether the temporal variability of other predictive factors, such as hormonal cycles, affects the probability of seizure occurrence and the prediction of seizures remains to be investigated 29 . Such factors do influence continuous EEG data collected over extended periods from humans going about their daily lives 9, [29] [30] [31] , and taking account of these factors is expected to improve seizure prediction in some individuals.
The nature of databases means that they can be used only for hypothesis generation because the data have already been collected, which renders a truly prospective analysis impossible. The same data in the databases are typically used repeatedly with different algorithms to assess seizure prediction performance, which reduces the reliability of the conclusions drawn. Findings based on databases do not enable definite conclusions about seizure prediction to be drawn but can suggest which algorithms are likely to perform well in prospective clinical trials by ruling out those that underperform even with retrospective data. fig. 1 ), conducted in conjunction with IWSP3 and IWSP4, involved continuous intracranial EEG data from three people with epilepsy 38 . Entrants were provided with a training set, and a test set was used to assess the algorithms entered into the competition. Of fewer than ten entrants, none achieved above-chance prediction performance.
Box 1 | Defining pre-ictal biomarkers
A pre-ictal biomarker is a predictive characteristic (or feature) derived from physiological signals (for example, eeG signals) that becomes apparent during a defined time period before a seizure and does not occur at other times. Such a characteristic might or might not be visually apparent, will reflect changes in the underlying signals and would be predictive of seizures when within a specific range of values. characteristics are used rather than the raw signals because they simplify the essential changes in the signals. For a pre-ictal biomarker to be clinically useful in a warning system, it should be detectable early enough to minimize the time under false warning.
characteristics that have been assessed for their predictive value, particularly those of EEG signals, range from simple to complex and involve univariate, bivariate or multivariate linear or nonlinear analysis. the seizure prediction properties of individual characteristics can be assessed independently, but combinations of characteristics are often provided as input to pattern recognition systems, machine learning algorithms or classifiers. these classifiers enable assessment of the seizure prediction properties of characteristics in combination 39, 174, 215 .
In 2014 and 2016, large-scale international seizure prediction competitions were run on a standard data science contest portal 13, 39 . The 2014 competition (American Epilepsy Society Seizure Prediction Challenge; see Related links) involved a combination of short-term human intracranial EEG data (with 942 seizures recorded over >500 days) and long-term intracranial EEG data in dogs (348 seizures recorded over 1,500 days) 39, 40 . All entrants were provided the same set of discontinuous 10 min segments of inter-ictal and pre-ictal data for training their algorithm; additional unlabelled 10 min segments of EEG recordings from the same people with epilepsy were then provided for testing their algorithm. Although less ideal than the use of continuous data 8 , this approach was more tractable for the entrants and the evaluators, given the large amounts of data involved. The 2016 contest (Melbourne University AES/MathWorks/NIH Seizure Prediction; see Related links) involved long-term intracranial EEG data (1,139 seizures recorded over 1,326 days) from three people with epilepsy whose seizures were hard to predict with existing approaches 9, 13 . The structure of the competition was similar to the one run in 2014. Combined, the 2014 and 2016 contests had more than 1,200 participants and included many who had not previously been active in the field of seizure prediction.
Evaluation of seizure prediction algorithms in both contests involved the use of the AUC metric ( fig. 3) . The top-performing entry in the 2014 contest was based on a combination of various machine learning algorithms and produced an AUC value of 0.84 out of 1 (ref.
39
). The performance of this algorithm dropped by only 8% when applied to a much larger data set. The top algorithm from the 2016 contest produced a similar AUC value of 0.81 for long-term human data 13 . Although competitions are highly compelling and enable standardized comparison of algorithms, they also raise new challenges in the assessment of seizure prediction algorithms. A large number of algorithms were assessed, and some might have performed well by chance. Without appropriate statistical correction for multiple testing, unwarranted positive conclusions about a seizure prediction algorithm are possible. A statistical comparison test of the methods, including correction for multiple comparisons, was performed for the 2016 competition and indicated that no one algorithm is best for a given person; rather, sets of algorithms work better than other sets of algorithms for a given person 13 .
A prospective seizure prediction system. To date, only one clinical trial of a fully functioning seizure prediction system, which the investigators who developed it described as a seizure advisory system 9 , has been conducted. The system consisted of intracranial implanted electrodes connected by subdermal wires to a subdermal telemetry unit implanted in the chest, which wirelessly transmitted the EEG data to a handheld unit (fig. 2b) . This unit processed the data in real time using an individualized algorithm and displayed warning lights to the person depending on whether the likelihood of a seizure was high, moderate or low. The study consisted of two phases. In the first phase, the device was implanted and data were recorded continuously until the required number of seizures had occurred. These data were analysed offline to identify an individual-specific algorithm. Fifteen people with epilepsy received an implant, and eleven completed the first phase; an algorithm was developed for nine people who experienced sufficient seizures to enable statistical assessment of the algorithms. These nine individuals then entered the second phase, in which the developed algorithm was run prospectively in real time for 4 months.
Prospective seizure prediction was above chance for nine people and was excellent for three in whom prospective seizure prediction sensitivities (the percentage of seizures correctly predicted) were 86%, 100% and 100% for thirteen, three and three seizures, respectively, during the evaluation period. The percentage of time for which these three individuals were under a warning of high seizure likelihood was 27%, 31% and 3%, respectively. In the other six people, the sensitivity ranged between 54 and 71%, and the percentage of time under high seizure likelihood warning ranged between 15 and 41%.
This trial was a landmark study in the field of seizure prediction and remains the only successful demonstration of prospective human seizure prediction to date 9 . Another major aspect that contributes to the importance of the study is that it involved human intracranial EEG recordings of up to 3 years per person. Standard inhospital intracranial recordings in ambulatory patients continue for a maximum of 4 weeks and do not necessarily include an adequate number of seizures to enable statistically reliable assessment of seizure prediction 8 . Furthermore, this study demonstrated that long-term recordings are possible, that seizure prediction algorithms seem to work best when developed in a patientspecific manner, that people with epilepsy are willing to volunteer for such studies, and that research ethics committees see the benefits of these trials. Thus, the door has been opened for more long-term prospective trials.
The field of seizure prediction has been encouraged by this first demonstration of feasibility of seizure prediction. The earliest studies of seizure prediction were restricted by limited data sets and computational power. Computing power has evolved, but the costs and practical challenges of acquiring long-term data sets that contain adequate numbers of seizures for reliable statistical evaluation remain considerable. Earlier studies or studies with limited data sets should not, therefore, be www.nature.com/nrneurol considered as failed attempts but rather as having laid the groundwork that made completion of a prospective clinical trial of seizure prediction possible.
Further work is needed to understand why seizure prediction performance was low for six of the nine assessable participants in the trial so that seizure prediction could be improved for these people 13 . The algorithms derived from such an analysis could be applicable to other people with epilepsy. More knowledge about the seizures experienced by people for whom the prediction algorithms performed poorly could help to better understand and better classify epilepsy. In addition, more knowledge about the seizures that were difficult to predict or were unpredictable is important, as this knowledge could lead to improvements in seizure prediction. Indeed, analysis of seizure statistics (such as seizure duration and frequency) from the trial data set 9, 15, 31, 41, 42 has identified factors that were related to poor seizure prediction; these factors included a high frequency of seizures 9 , long-term temporal variations in seizure frequency 30 , and multimodal distributions of seizure duration and inter-ictal intervals 31 . The analysis also identified factors associated with good seizure prediction, including an increase in the frequency of EEG spikes before seizures 41 . This observation suggests that characterization of an individual's seizure and spike statistics can improve prediction performance and that more than one predictive factor is required for people with multimodal distributions of seizure duration. However, contradictory findings on the role of EEG spikes and their temporal relationship to seizures add uncertainty. This area remains under investigation [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] . An analysis of long-term recordings published in 2018 has produced results that are consistent with those of the trial 41 and that indicate that seizures occur preferentially during the rising phase of multi-day rhythms of inter-ictal epileptiform activity 54 . Analysis of the trial data set also indicates that incorporating factors such as the time of day is another potential avenue for improving prediction 13, 15 .
Emerging science for seizure prediction Many existing studies of seizure prediction have been performed with little consideration of the mechanisms that underlie the transition from apparently normal brain activity to seizure. Most studies have also been performed with EEG, a modality that does not lend itself to determination of underlying mechanisms. Furthermore, analysis with techniques such as machine learning does not readily reveal which physiological aspects underlie the predictive characteristics of EEG data. These approaches, though commendable for their pragmatism, have resulted in a limited understanding of the mechanistic underpinnings of the pre-ictal state. An understanding of the underlying mechanisms will result in a better understanding of ictogenesis, better translation of the information collected into methods for the detection, prediction and control of seizures, and eventually a better understanding of what a seizure is 55 . Several lines of investigation have indicated potential to provide a deeper understanding of ictogenesis and the pre-ictal period. Below, specific emerging areas and their implications for seizure prediction are discussed.
A network theory of seizure generation. Traditionally, seizures are thought to result from an imbalance between excitation and inhibition 56 in a discrete cortical area (the seizure focus), resulting in seizure initiation and subsequent recruitment of adjacent cortex into the escalating seizure. By contrast, the network theory proposes that even focal seizures arise from aberrant activity in a distributed network and that a change in the configuration or in the activity of a large-scale functional network that spans lobes and hemispheres makes the brain more susceptible to seizure 57, 58 . Many studies have indicated aberrant connectivity involving the seizure-onset zone, its surroundings and distant areas. In addition, seizurepredictive characteristics can occur in brain regions with no apparent relationship to the assumed seizure-onset zone 83 , thereby questioning the importance of the seizureonset zone in the generation of a seizure. Furthermore, seizures do not occur randomly and have been shown to have short-range 84, 85 and long-range 30,86 temporal dependencies. Development of methods to measure and track key network variables could improve seizure prediction.
Analysis techniques that enable the assessment of connectivity between brain regions in a time-resolved manner on the basis of the ongoing EEG 83, [87] [88] [89] [90] in combination with the concepts of network theory that aim to characterize local and global properties of epileptic networks [91] [92] [93] [94] [95] [96] [97] [98] could further our understanding of how seizures emerge from an epileptic network [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] . Considering the epileptic network to be evolving rather than static could help to gain deeper insights into when and from which nodes seizures emerge 96, . Challenges in the development of a network theory for seizure prediction include difficulty in sampling the evolving epileptic brain network with sufficient spatial and temporal resolution with current techniques and uncertainty about where seizures will start within the network, making it difficult to position sensors in the correct place. Advances in measurement techniques 122 and conceptual advances in network theory and statistical physics will enable better definition of the epileptic network and pre-ictal changes in the network.
Multiscale electrophysiology. Technological developments have led to use of micro-electrodes 123, 124 that, compared with EEG, provide new levels of temporal and spatial resolution and enable measurement of local field potentials and single neuron activity in humans during inter-ictal, pre-ictal and ictal states [125] [126] [127] [128] [129] [130] . This technology has enabled observation of phenomena such as microseizures and complex interactions between neuronal groups on various spatial scales, and these observations challenge the traditional view that seizures result from a monolithic, hyper-synchronous neuronal event stemming from runaway excitation [125] [126] [127] [128] [129] [130] . Such high-resolution recording is an emerging area of electrophysiology that should help with the interpretation of previous work conducted with macroelectrophysiology. Challenges remain, such as increasing the number of neurons that can be sampled, improving spatial coverage and clarifying the relationship between neuronal activity and EEG. Nevertheless, the processing power of wearable and implantable devices continues to accelerate, and these advances will, with time, provide the capacity for seizure prediction devices to handle the amount of data from multiscale recordings.
Multimodal biosensing. The use of multimodal biosensing and emerging wearable devices is expected to improve seizure prediction (RADAR-CNS; see Related links) because physiological variables can be detected through this approach that cannot be detected with traditional approaches 4 . The availability of a library of methods that are sensitive to different physiological variables will enable clinicians to use appropriate methods for a given individual. Several techniques and approaches, discussed below, show promise.
Neurochemistry studies in people with epilepsy and in animal models of epilepsy indicate an excess of extracellular glutamate [131] [132] [133] [134] and changes in extracellular glutamine 135, 136 in the seizure-onset zone and zones to which the seizure spreads. Measurements in human hippocampal tissue slices have indicated an increase in glutamate in the same areas around the time of a seizure 137 , though whether these changes precede seizures remains to be determined 138 . Inhibition during the pre-ictal period might also be important, given that pre-ictal changes in GABA A receptor-mediated chloride influx is observed in mice neurons 139 , and the inhibitory penumbra has a role in seizure propagation in animals and humans 127, 130 . Several non-neurological pre-ictal changes could also help with seizure prediction. Evidence suggests that cardiac autonomic function, cerebral haemodynamics 140 (which might reflect changes in neuronal activity that are not readily detectable with EEG) and vascular coupling 141, 142 change in the pre-ictal period. Limited evidence also indicates pre-ictal changes in heart rate. In one small study, heart rate during the 2 min before onset of a focal-onset seizure was higher among people whose seizures became generalized than those whose seizures did not 143 . Similarly, cardiac vagal tone, which partly controls heart rate, was higher before focal-onset seizures that became generalized than those that did not 144 . A meta-analysis of pre-ictal changes in heart rate suggests that such changes are observable in some but not all individuals, and further work is needed to determine for which patients heart rate monitoring would be useful for seizure prediction 145 . Several studies in childhood absence epilepsy have suggested that blood-oxygen-level-dependent activity increases several seconds before the onset of spikewave discharges (SWDs) 146, 147 . However, not all studies have shown this 148 , and whether the pre-ictal cortical phenomena are the first emergence of seizure activity or a seizure-permissive (but otherwise normal) brain state remains unclear. Such pre-ictal activity has been observed in posterior cortical regions, especially the precuneus 146, 147, 149, 150 , and in frontal cortical regions, such as the orbital and medial frontal cortex 146, 149 . Thalamic activity was generally not seen until SWD onset, except in one study in which thalamic activity preceded SWD onset by several seconds 151 . In a single case report, focalonset seizures recorded intraoperatively were preceded by a drop in oxygenated haemoglobin and an elevation in cerebral blood volume in the seizure-onset region 20 s before electrographical changes 152 . In temporal lobe epilepsy, single-photon emission CT usually shows decreases in regional cerebral blood flow (rCBF) in the ictal-onset temporal lobe in the inter-ictal state compared with that during the pre-ictal and ictal periods in the same individual and compared with that in healthy people. In individuals who, by chance, underwent single-photon emission CT 11 min and 12 min before seizure onset, rCBF was increased relative to the interictal period in the same person, suggesting that rCBF increases before seizure onset 153 . Studies in which transcranial magnetic stimulation has been used to assess cortical excitability 154 have indicated increased excitability in people who go on to have seizures within the next 24-48 h (refs 155, 156 ). The combination of this finding with data from computational modelling studies [157] [158] [159] [160] indicates that measurement of cortical excitability by use of a probing stimulus [161] [162] [163] is an alternative to passive observation for tracking state changes in the brains of people with epilepsy.
Computational modelling. The information gathered from multiscale and multimodal studies of epilepsy have stimulated the development of increasingly sophisticated computational modelling approaches [164] [165] [166] [167] [168] [169] . These approaches have gained prominence over the past decade as important tools for understanding the complexity of seizures and epilepsy at various spatial and temporal scales. The spatial scales range from microscale modelling of single neuron behaviour to macroscale modelling of brain activity, each of which can be used not only for modelling seizure-like activity and the apparently unforeseeable onset and termination of seizures but also for gaining insight into possible mechanisms of controlling seizures, such as closed-loop electrical www.nature.com/nrneurol intervention. Between these two extremes are mesoscale models, such as neural mass models 10, [170] [171] [172] [173] [174] [175] [176] , which are intended to finely balance model simplification with biological realism to address relevant questions. In all three types of models, epilepsy is considered a dynamical brain disease 177 in which the initiation of seizures can, in general, be induced by changes in network parameters or by inputs (environmental and/or endogenous) that might not always be evident to an observer 178 . On the basis of key concepts from the mathematical theory of dynamical systems 179 , seizures are thought to be enabled by criticality -that is, the loss of balance between order and disorder in the epileptic brain 180, 181 . In this context, a seizure represents a self-initiated and self-terminated event that emerges as a result of bistability of the brain 160, [182] [183] [184] , a property that allows spontaneous switching from seemingly normal physiological dynamics to periods of pathological activity. Evidence indicates that such switching might be induced not only by altered properties of neurons or groups of neurons but also by changes in the gross connections of the neuronal network 57, [185] [186] [187] [188] [189] [190] [191] [192] . Given their increasing sophistication, computational models can help to integrate the structural, functional and dynamical properties of neural systems into a coherent view and to test in silico hypotheses concerning preictal brain dynamics and their relation to endogenous and exogenous parameters that control the dynamics. Moreover, such models enable the study of aspects of the epileptic brain that cannot be explored in human studies owing to safety concerns. Such computational modelling could inform the development of methods for seizure prediction 10 and of engineering techniques, such as control theory 193 , to determine physiological parameters that control the generation, spreading and termination of seizures over time 173, 194 and to track brain states 195 on the basis of these parameters. The use of modelling-based approaches will allow for physiologically informed methods of seizure prediction that offer an alternative to standard machine learning techniques, which take little physiological knowledge into account and yield little insight into the underlying physiology. Moreover, the combination of data and modelling will help to leverage techniques for intervention strategies and seizure control 196, 197 .
Unmet needs for clinical translation
Collaborative efforts in the field of seizure prediction over the past three decades have resulted in a powerful international interdisciplinary effort to understand and control seizures, which has led to the considerable progress discussed above. However, much remains to be completed in the coming years, and several open questions need to be answered to advance the field of seizure prediction.
Understanding of seizures.
Research has demonstrated that epilepsy is a multiscale problem 10 , meaning that spatially sparse recordings with few intracranial EEG electrodes are unlikely to provide a full understanding. However, whether the accurate placement of electrodes is critical for the detection of seizure precursors is not known. Given the variability of seizures between different people with epilepsy (and variability of seizures even within an individual), how to standardize electrode placement remains unclear. The minimum requirement is likely to be sampling of nodes in an individual's epileptic network that are associated with seizure precursors.
Success in seizure prediction has enormous potential to improve our understanding of seizures and epilepsy and to provide direction for research. The existence of a pre-ictal state is unproven but is logically inferred from the predictability of seizures. What this state is and its characteristics, however, are unknown. A better understanding of the dynamic transitions into and out of seizures will contribute not only to prediction but also to our understanding of what constitutes a seizure. Computational modelling and analysis have challenged the accepted wisdom that seizures result from out-of-control excitation and raised questions about network involvement and the role of aberrant synchronization. New computational approaches (such as those based on network theory) are also raising questions about the processes that underlie ictogenesis and epileptogenesis.
Critical experiments. With all the aforementioned challenges in mind, critical experiments need to be performed to understand how seizures occur and how a physiological understanding can be used to predict seizures. The ideal critical experiment would be multidisciplinary, drawing on a combination of multiscale electrophysiology and chemical physiology 126, 138, 198 , structural and functional imaging 199 , mathematical and computational modelling 169 and potentially optogenetics 200 . Modelling will be important for testing hypotheses and filling in missing data when empirical methods come up short 10 . These approaches should be combined to determine what seizures are and why they occur; the sequence of brain activity that leads to a seizure; whether a pro-ictal 201 state of the brain makes seizures more likely or whether transition to seizure is deterministic (and whether this depends on the individual and the type of epilepsy); reliable and robust biomarkers of these sequences that do not result in excessive false warning time; and how these aspects are affected by infradian and multi-day cycles 13, 15, 54 , stress and anti-epileptic drugs 163 . Similarly, despite good evidence that seizures are predictable, we are far from seeing a commercially available seizure prediction device. To reach this point, crucial experimental evidence remains to be acquired. These critical studies need to incorporate the following aspects: use of continuous data rather than selected discontinuous periods; demonstration that seizure prediction works and has benefits; and use of technology (Box 2) that is safe, reliable, stable over time, acceptable, beneficial to people with epilepsy and applicable to and useful for a large percentage of people with epilepsy.
Improved databases and contests. Seizure prediction databases and seizure prediction contests have been valuable but suffer from limitations. Databases need to be improved to include multiscale and multimodal data, and monitoring should be standardized. The heterogeneity of epilepsy must also be addressed. For example, if a subset of people experience seizures that are more predictable than others, identification of these people and a better understanding of seizure generation in them could provide an invaluable 'foot in the door' for the control of seizures through seizure prediction.
With regard to seizure prediction competitions, detailed peer-reviewed accounts of the algorithms entered into the 2014 contest 39 were not published, and the algorithms merely predicted whether segments of EEG recordings were from inter-ictal or pre-ictal periods rather than providing a more clinically informative evalu ation of seizure prediction performance on the basis of continuous data. These contests have brought new investigators into the field and generated hypo theses about which algorithms were good predictors. Future competitions could add more value if they are based on multimodal data and assess the computational efficiency of algorithms. Correction for multiple comparisons should be performed to account for the number of algorithms entered, and a mechanistic interpretation of the algorithm outputs should be required.
An attractive possibility is the use of seizure prediction databases or competitions as objective benchmarking exercises in which algorithms are submitted to a central authority that tests them with unrevealed data. If such a process could be conducted in a manner that enabled regulatory bodies to accept the results as proof of efficacy, it would be of considerable value 13 .
Expansion of continuous data collection. The only system that has been used successfully for real-time, prospective seizure prediction required a brain-implantable device 9 , which raises ethical concerns. Non-invasive solutions, such as attachment of electrodes to the scalp or use of a cap or headband with electrodes attached, are unlikely to be satisfactory long-term solutions because frequent maintenance would probably be required to obtain good signals, and the electrodes might be obvious and raise concerns of stigma. Semi-invasive subdermal systems might be viable alternatives, although the predictive value of data obtained in this way is unknown, and, as with intracranial electrodes, standardized placement of electrodes is not yet possible. Furthermore, the challenge of creating a system that can be used continuously for the life of an individual, including children, has not yet been tackled. If modalities other than EEG prove valuable for seizure prediction, the challenge of continuous acquisition of these data must be overcome [202] [203] [204] [205] [206] .
Defining outcomes relevant to patients. People with epilepsy are vital participants in the next steps in seizure prediction, especially because the regulatory framework around such a novel approach might be uncharted. The opinions and aspirations of these individuals are essential for future planning. For example, whether a solution should be invasive or non-invasive, whether prediction needs to be 100% accurate and whether a predictive signal alone is useful without connection to a therapy are questions best answered by people with epilepsy [207] [208] [209] . A short-term goal in the field might be to develop a close interaction between patient groups, researchers and industry to develop patient-centred goals.
Successful trial to commercialization. Above-chance seizure prediction based on EEG has been demonstrated in humans and animals (Box 3). Given this scientific success, an important challenge is the commercialization of a seizure prediction device. The results of the clinical trial described above did not justify commercialization of the device used. The design of future trials will need to account for the lessons learned from this trial. Many studies have demonstrated that not all people with epilepsy have seizures that can be predicted and that not all of an individual's seizures are predictable; future work will be needed to define epilepsy phenotypes or endophenotypes that are associated with predictability 83 . Moreover, careful work will be needed to determine several aspects, including acceptable end points for regulatory approval, such as the predictive accuracy needed for a device to be declared effective; the gold standard for detecting seizures, given that seizure diaries are unreliable 9, [210] [211] [212] ; whether a device that merely predicts seizures would be acceptable to regulators without being directly connected to a closed-loop delivery of treatment; and what treatment modality a device could be connected to. Currently, no attempt has been made to connect a seizure-predictive characteristic with a therapy in human trials.
Guidelines revisited
In the 2007 review of seizure prediction 8 , minimum requirements were proposed to ensure that published prospective and retrospective seizure prediction studies are comprehensible, comparable and assessable. These requirements stated that studies should be based on unselected continuous data, report sensitivity and specificity together with a rigorous statistical evaluation and provide details about the studies themselves, including the use of in-sample or out-of-sample testing . moreover, partial success of the trial in demonstrating prospective seizure prediction in some individuals has given the field the confidence to move forward while recognizing that improvements are still needed 13 . other brain-implantable devices [216] [217] [218] offer opportunities to apply and assess seizure prediction algorithms. Furthermore, minimally invasive recording techniques that position electrodes under the scalp 219 are likely to open the door to more opportunities for long-term recording.
one potential application of seizure prediction is activation of seizure control 220 interventions such as electrical stimulation, tissue cooling or anti-convulsant drug delivery. two approaches to controlling seizures are possible. First, the impending seizure can be targeted, but prediction of all seizures or prevention of all seizures that are successfully predicted might not be possible. Second, probabilistic or neuromodulatory approaches might be used to steer the brain away from a seizuregenerating state and to maintain the brain in a state where a seizure will not occur. translating a new modality from the laboratory to continuous real-world monitoring that allows individuals to go about their daily life requires a solution that is robust, longlasting (potentially the entire life of an individual), unobtrusive, safe, efficacious and acceptable to regulatory bodies. research and development is also required to minimize power consumption, heat generation and the form factor and to address device placement, retrieval and replacement. the capability to address these multiple aspects does not exist in a single institution or company, suggesting the need for collaborations to translate new insights into a successful seizure prediction device.
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For trials of wearable and implanted devices 16, 213, 214 , additional important criteria are the real-time applicability and the power-efficiency of solutions. Algorithms that need minimal computation or that can be approximated with low-power circuitry should be favoured. Low-complexity algorithms that perform inadequately could still provide a good benchmark for more complex algorithms. In general, algorithms that are more likely to provide a pathophysiological understanding of the disease and the ictogenic process should be favoured over others.
Conclusions
Considerable progress has been made in seizure prediction during the past three decades, especially since 2007. Technological progress has enabled us to measure relevant signals from increasing numbers of sensors, including increasingly small sensors that enable multiscale observation with high spatial and temporal resolution, and to collect data over longer periods of time. This progress has led to the creation of large-scale databases and seizure prediction competitions. At the same time, the earlier focus on seizure prediction algorithms has continued. In addition, the practical necessities for the collection, sharing and standardization of seizure prediction data are being addressed, and work towards seizure prediction in wearable or implantable devices is being performed.
The formation of an international group of seizure prediction laboratories that meets regularly 10, 23, [32] [33] [34] [35] [36] [37] has led to the establishment of several international academic and industry-academic partnerships. The group has identified several of the above challenges and articulated suggestions for addressing these challenges. We are hopeful that the remaining challenges will be solved in the near future so that seizure prediction can improve the lives of people with epilepsy.
Published online 21 August 2018
Box 3 | Seizure prediction in animals Seizure prediction has been studied in many animal models of epilepsy, commonly in rats, but obtaining recordings in rats for longer than 6 months is challenging. Another challenge with animal models is the translation of findings to human application. Animal models do not always generalize well to humans, so predictors defined in animal models might not generalize either.
the strongest evidence that seizure prediction is possible in animals comes from long-term recordings in dogs. Studies have shown that seizure prediction performs better than chance in all dogs studied 39, 40, 221 . these results are especially important because the recordings were obtained in naturally occurring epilepsy over durations of up to 15 months, which increases confidence in the performance results achieved and indicates that seizure prediction is possible in general.
and optimization strategies. These guidelines remain relevant, but we propose updates to complement them and account for subsequent advances in the field.
As the field moves closer to clinical trials, common standards for clinical trial reporting must be adopted. These standards include clear reporting of the criteria for selection of patients and data, the inclusion and exclusion criteria, and the gold standard for the location and types of sensors to measure the timing and occurrence of seizures. Various measures of specificity have been published 8 , and the most intuitive measure seems to be the time under false warning. Unblinded studies, especially those that are based on retrospective data, should be regarded as hypothesis-generating only; any study that is intended to be definitive should be randomized, controlled, double-blinded and prospective, the protocol should be published, and assessment criteria for success should be clearly defined. Outcomes of these trials should be publicly available irrespective of their success to prevent the revisiting of unsuccessful approaches and to avoid publication bias.
